Somnomed Ltd
ASX:SOM

Watchlist Manager
Somnomed Ltd Logo
Somnomed Ltd
ASX:SOM
Watchlist
Price: 0.77 AUD 1.99% Market Closed
Market Cap: 168m AUD

Somnomed Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Somnomed Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Somnomed Ltd
ASX:SOM
Revenue
AU$111.5m
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
12%
C
Cyclopharm Ltd
ASX:CYC
Revenue
AU$29.7m
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
11%
Cochlear Ltd
ASX:COH
Revenue
AU$2.3B
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
10%
Optiscan Imaging Ltd
ASX:OIL
Revenue
AU$952k
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
32%
Austco Healthcare Ltd
ASX:AHC
Revenue
AU$81.4m
CAGR 3-Years
31%
CAGR 5-Years
20%
CAGR 10-Years
N/A
EMvision Medical Devices Ltd
ASX:EMV
Revenue
AU$5.6m
CAGR 3-Years
9%
CAGR 5-Years
42%
CAGR 10-Years
N/A
No Stocks Found

Somnomed Ltd
Glance View

Market Cap
166.4m AUD
Industry
Health Care

SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-08-27. The firm provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. SomnoMed has developed the SomnoDent, a collection of oral devices. SomnoDent includes two product line, such as signature line and standard line. Its signature line products include Herbst Advance Elite, Fusion, Flex and Classic, and standard line products include Herbst Advance, Air/Air+, Morning Repositioner and Alpha. SomnoMed has developed the SomnoBrux, a custom fit acrylic occlusal splint. SomnoBrux product includes Michigan. SomnoMed has developed the SomGauge, is an autoclavable instrument, which can be used to construct accurate and reliable bite records.

SOM Intrinsic Value
0.76 AUD
Overvaluation 2%
Intrinsic Value
Price

See Also

What is Somnomed Ltd's Revenue?
Revenue
111.5m AUD

Based on the financial report for Jun 30, 2025, Somnomed Ltd's Revenue amounts to 111.5m AUD.

What is Somnomed Ltd's Revenue growth rate?
Revenue CAGR 10Y
12%

Over the last year, the Revenue growth was 22%. The average annual Revenue growth rates for Somnomed Ltd have been 15% over the past three years , 14% over the past five years , and 12% over the past ten years .

Back to Top